Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1987 Sep-Oct;60(5):391–396.

Stimulus-specific effects of endotoxin on superoxide production by rabbit polymorphonuclear leukocytes.

J T Rosenbaum 1, H Enkel 1
PMCID: PMC2590342  PMID: 2827396

Abstract

The release of superoxide (O2-) by polymorphonuclear leukocytes (PMN) is an important function that contributes to microbial death. Controversy exists as to the effect of bacterial endotoxin (lipopolysaccharide, or LPS) on the production of O2-. We have injected rabbits with 25 micrograms Escherichia coli LPS intravenously and studied PMN function 18 to 24 hours later. Relative to PMN from saline-injected controls, PMN from LPS-treated rabbits released markedly greater amounts of O2- in response to 10 ng/ml phorbol myristate acetate (PMA) as measured by nmol cytochrome C reduced in 20 minutes (40.8 +/- 7.8 for LPS-treated PMN versus 10.1 +/- 1.6 for control, p less than 0.01). LPS injection, however, significantly reduced O2- release in response to C (complement) 5a (1.4 +/- 0.6 nmole/20 minutes for LPS-treated PMN versus 5.6 +/- 1.3 nmole/20 minutes for control, p less than 0.01). O2- release in response to a third stimulus, n-formyl-methionyl-leucyl-phenylalanine (10(-7) to 10(-9) M), was not affected by LPS. O2- release in response to PMA was enhanced over a wide range of PMA concentrations (10 to 300 ng/ml). Kinetic studies over 30 minutes indicated that, after a brief initial latency in measurable response, LPS enhanced responsiveness to PMA at all time points observed. The reduced responsiveness to C5a corresponds to a previously reported down regulation of receptors for this ligand after intravenous LPS. The observations indicate that intravenous LPS can alter a critical function of PMN for at least 24 hours in a stimulus-specific manner.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour A. G., Allred C. D., Solberg C. O., Hill H. R. Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis. 1980 Jan;141(1):14–26. doi: 10.1093/infdis/141.1.14. [DOI] [PubMed] [Google Scholar]
  2. Becker E. L., Kermode J. C., Naccache P. H., Yassin R., Marsh M. L., Munoz J. J., Sha'afi R. I. The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol. 1985 May;100(5):1641–1646. doi: 10.1083/jcb.100.5.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goldman D. W., Enkel H., Gifford L. A., Chenoweth D. E., Rosenbaum J. T. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. J Immunol. 1986 Sep 15;137(6):1971–1976. [PubMed] [Google Scholar]
  4. Guthrie L. A., McPhail L. C., Henson P. M., Johnston R. B., Jr Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med. 1984 Dec 1;160(6):1656–1671. doi: 10.1084/jem.160.6.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hartiala K. T., Langlois L., Goldstein I. M., Rosenbaum J. T. Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors. Infect Immun. 1985 Nov;50(2):527–533. doi: 10.1128/iai.50.2.527-533.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henricks P. A., van der Tol M. E., Thyssen R. M., van Asbeck B. S., Verhoef J. Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes. Infect Immun. 1983 Jul;41(1):294–301. doi: 10.1128/iai.41.1.294-301.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnston R. B., Jr, Keele B. B., Jr, Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., RaJagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest. 1975 Jun;55(6):1357–1372. doi: 10.1172/JCI108055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maridonneau-Parini I., Tringale S. M., Tauber A. I. Identification of distinct activation pathways of the human neutrophil NADPH-oxidase. J Immunol. 1986 Nov 1;137(9):2925–2929. [PubMed] [Google Scholar]
  9. McCall C. E., Bass D. A., DeChatelet L. R., Link A. S., Jr, Mann M. In vitro responses of human neutrophils to N-formyl-methionyl-leucyl-phenylalanine: correlation with effects of acute bacterial infection. J Infect Dis. 1979 Sep;140(3):277–286. doi: 10.1093/infdis/140.3.277. [DOI] [PubMed] [Google Scholar]
  10. McCall C. E., DeChatelet L. R., Cooper M. R., Shannon C. Human toxic neutrophils. 3. Metabolic characteristics. J Infect Dis. 1973 Jan;127(1):26–33. doi: 10.1093/infdis/127.1.26. [DOI] [PubMed] [Google Scholar]
  11. Moore F. D., Jr, Davis C., Rodrick M., Mannick J. A., Fearon D. T. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med. 1986 Apr 10;314(15):948–953. doi: 10.1056/NEJM198604103141503. [DOI] [PubMed] [Google Scholar]
  12. Proctor R. A. Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect Immun. 1979 Sep;25(3):912–921. doi: 10.1128/iai.25.3.912-921.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rosenbaum J. T., Hartiala K. T., Webster R. O., Howes E. L., Jr, Goldstein I. M. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro. Am J Pathol. 1983 Dec;113(3):291–299. [PMC free article] [PubMed] [Google Scholar]
  14. Schröder J. M., Christophers E. Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin. J Invest Dermatol. 1985 Sep;85(3):194–198. doi: 10.1111/1523-1747.ep12276664. [DOI] [PubMed] [Google Scholar]
  15. Takenawa T., Ishitoya J., Homma Y., Kato M., Nagai Y. Role of enhanced inositol phospholipid metabolism in neutrophil activation. Biochem Pharmacol. 1985 Jun 1;34(11):1931–1935. doi: 10.1016/0006-2952(85)90311-9. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES